-+ 0.00%
-+ 0.00%
-+ 0.00%

NURIX THERAPEUTICS ANNOUNCES GLOBAL COLLABORATION WITH ROCHE TO CO-DEVELOP AND CO-COMMERCIALIZE POTENTIAL BEST-IN-CLASS BTK DEGRADER BEXOBRUTIDEG ACROSS MALIGNANT HEMATOLOGY, IMMUNOLOGY AND NEUROLOGY

Reuters·06/08/2026 05:00:00

Please log in to view news